Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADGM NASDAQ:ATMV NASDAQ:MLEC NYSE:NYC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADGMAdagio Medical$0.90$1.17$0.74▼$2.58$20.01M-0.14106,157 shs44,030 shsATMVAlphaVest Acquisition$5.06-2.3%$6.49$5.43▼$42.00$16.30M-0.11229,874 shs44,777 shsMLECMoolec Science$8.48+1.7%$8.44$3.08▼$157.05$6.06M0.38205,601 shs13,272 shsNYCAmerican Strategic Investment$10.00+16.7%$8.33$7.03▼$16.30$23.08M0.218,249 shs31,888 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADGMAdagio Medical0.00%-5.48%-44.74%-8.55%-26.16%ATMVAlphaVest Acquisition-8.00%-25.48%-19.04%-21.18%-56.42%MLECMoolec Science+1.68%-5.57%+6.80%-3.42%-93.40%NYCAmerican Strategic Investment+16.69%+23.00%+26.90%+20.92%-8.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADGMAdagio Medical$0.90$1.17$0.74▼$2.58$20.01M-0.14106,157 shs44,030 shsATMVAlphaVest Acquisition$5.06-2.3%$6.49$5.43▼$42.00$16.30M-0.11229,874 shs44,777 shsMLECMoolec Science$8.48+1.7%$8.44$3.08▼$157.05$6.06M0.38205,601 shs13,272 shsNYCAmerican Strategic Investment$10.00+16.7%$8.33$7.03▼$16.30$23.08M0.218,249 shs31,888 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADGMAdagio Medical0.00%-5.48%-44.74%-8.55%-26.16%ATMVAlphaVest Acquisition-8.00%-25.48%-19.04%-21.18%-56.42%MLECMoolec Science+1.68%-5.57%+6.80%-3.42%-93.40%NYCAmerican Strategic Investment+16.69%+23.00%+26.90%+20.92%-8.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADGMAdagio Medical 2.25Hold$3.50288.54% UpsideATMVAlphaVest Acquisition 1.00SellN/AN/AMLECMoolec Science 0.00N/AN/AN/ANYCAmerican Strategic Investment 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest MLEC, NYC, ADGM, and ATMV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2026ADGMAdagio Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)4/20/2026NYCAmerican Strategic Investment Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/15/2026ADGMAdagio Medical Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold4/14/2026ADGMAdagio Medical Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$3.004/14/2026ADGMAdagio Medical Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$3.00(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADGMAdagio Medical$600K33.34N/AN/A$0.26 per share3.46ATMVAlphaVest AcquisitionN/AN/AN/AN/AN/AN/AMLECMoolec Science$333.61M0.02N/AN/A($309.64) per share-0.03NYCAmerican Strategic Investment$43.28M0.62N/AN/A$24.05 per share0.42Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADGMAdagio Medical-$25.08M-$1.53N/AN/AN/AN/A-382.50%-64.98%5/21/2026 (Estimated)ATMVAlphaVest AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AN/AMLECMoolec Science-$111.46M-$33.00N/AN/AN/AN/AN/AN/A5/28/2026 (Estimated)NYCAmerican Strategic Investment-$21.19M-$8.80N/AN/AN/A-48.97%-105.28%-14.10%5/15/2026 (Estimated)Latest MLEC, NYC, ADGM, and ATMV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2026N/AADGMAdagio Medical-$0.29N/AN/AN/AN/AN/A5/14/2026Q2 2026MLECMoolec ScienceN/A$47.4870N/A$47.4870N/A$2.62 million5/12/2026Q1 2026ADGMAdagio Medical-$0.29-$0.31-$0.02-$0.31N/AN/A4/20/2026Q4 2025ATMVAlphaVest AcquisitionN/A-$1.03N/A-$1.03N/A($24.85) million4/15/2026Q4 2025NYCAmerican Strategic Investment-$1.72-$2.62-$0.90-$2.62$14.39 million$6.48 million3/27/2026Q4 2025ADGMAdagio Medical-$0.31-$0.21+$0.10-$0.21N/A($0.13) millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthADGMAdagio MedicalN/AN/AN/AN/AN/AATMVAlphaVest AcquisitionN/AN/AN/AN/AN/AMLECMoolec ScienceN/AN/AN/AN/AN/ANYCAmerican Strategic InvestmentN/AN/A-100.00%N/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADGMAdagio Medical4.001.852.24ATMVAlphaVest AcquisitionN/AN/AN/AMLECMoolec ScienceN/AN/AN/ANYCAmerican Strategic Investment1.530.030.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADGMAdagio Medical48.08%ATMVAlphaVest Acquisition46.08%MLECMoolec Science0.07%NYCAmerican Strategic Investment48.04%Insider OwnershipCompanyInsider OwnershipADGMAdagio Medical5.20%ATMVAlphaVest Acquisition55.20%MLECMoolec Science19.90%NYCAmerican Strategic Investment1.74%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADGMAdagio Medical8722.21 million21.06 millionN/AATMVAlphaVest AcquisitionN/A3.22 million1.44 millionNot OptionableMLECMoolec Science4730,000582,000Not OptionableNYCAmerican Strategic InvestmentN/A2.69 million2.65 millionNot OptionableMLEC, NYC, ADGM, and ATMV HeadlinesRecent News About These CompaniesAmerican Strategic Investment Co. Announces Release Date for First Quarter 2026 ResultsMay 8, 2026 | businesswire.comEquity Issuance Settles Advisory Fees, Preserves LiquidityMay 1, 2026 | tipranks.comAmerican Strategic Investment Co. (NYSE:NYC) Q4 2025 Earnings Call TranscriptApril 16, 2026 | insidermonkey.comAmerican Strategic Investment Co. Sees Promising Year End 2025 Earnings with Strong Focus on Tenant Retention and Cost EfficiencyApril 16, 2026 | news.themarketisopen.comNAmerican Strategic Investment outlines potential sales of 123 William Street and 196 Orchard while maintaining 80.3% occupancyApril 16, 2026 | msn.comAmerican Strategic Investment Co. (NYC) Q4 2025 Earnings Call Prepared Remarks TranscriptApril 16, 2026 | seekingalpha.comAmerican Strategic Investment Co (NYC) Q4 2025 Earnings Call Highlights: Navigating Challenges ...April 16, 2026 | finance.yahoo.comAmerican Strategic Investment Details Strategic Portfolio Repositioning PlanApril 15, 2026 | tipranks.comAmerican Strategic Investment Co. Announces Fourth Quarter 2025 ResultsApril 15, 2026 | businesswire.comAmerican Strategic Static Ahead of NumbersApril 10, 2026 | baystreet.caNew York City REIT Schedules Q4 and 2025 ResultsApril 10, 2026 | tipranks.comAmerican Strategic Investment Co. Announces Updated Release Date for Fourth Quarter and Full Year 2025 ResultsApril 10, 2026 | businesswire.comAmerican Strategic Investment Co. Delays Annual FilingApril 1, 2026 | tipranks.comAmerican Strategic Investment Reschedules 2025 Earnings Release DateMarch 26, 2026 | tipranks.comAmerican Strategic Investment Co. Delays 4Q ResultsMarch 25, 2026 | marketwatch.comAmerican Strategic Investment Co. Updates Date for Fourth Quarter and Full Year 2025 ResultsMarch 25, 2026 | businesswire.comAmerican Strategic Investment Co. Announces Release Date for Fourth Quarter and Full Year 2025 ResultsMarch 9, 2026 | businesswire.comInsider Buying: American Strategic Investment (NYSE:NYC) Major Shareholder Buys $17,521.92 in StockJanuary 30, 2026 | insidertrades.comAmerican Strategic Investment (NYSE:NYC) Major Shareholder Buys $14,168.70 in StockJanuary 24, 2026 | insidertrades.comAmerican Strategic Investment (NYSE:NYC) Major Shareholder Buys 1,224 SharesJanuary 17, 2026 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMLEC, NYC, ADGM, and ATMV Company DescriptionsAdagio Medical NASDAQ:ADGM$0.90 0.00 (0.00%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$0.90 +0.00 (+0.02%) As of 04:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.AlphaVest Acquisition NASDAQ:ATMV$5.06 -0.12 (-2.32%) As of 05/13/2026AlphaVest Acquisition Corp does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2022 and is based in New York, New York.Moolec Science NASDAQ:MLEC$8.48 +0.14 (+1.68%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$8.25 -0.23 (-2.71%) As of 04:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.American Strategic Investment NYSE:NYC$10.00 +1.43 (+16.69%) As of 05/14/2026 03:18 PM EasternAmerican Strategic Investment Co. (NYSE: NYC) owns a portfolio of high-quality commercial real estate located within the five boroughs of New York City. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas YETI Rallies After Earnings Beat and Raised Outlook Cisco’s Vertical Rally May Still Be in the Early Innings Dividend Growth or High Yield: The Income Investor's Bet Nebius Upside Expands as AI Feedback Loop Intensifies Oklo Stock Could Be Ready for Another Massive Run Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell Qualcomm Stock Doubles: New Era? Or Another False Start? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
